MAI Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
1,979
+825
+71% +$381K ﹤0.01% 948
2026
Q1
$554K Buy
1,154
+994
+621% +$509K ﹤0.01% 986
2025
Q4
$89.9K Buy
160
+6
+4% +$3.41K ﹤0.01% 1707
2025
Q3
$79.2K Sell
154
-71
-32% -$31K ﹤0.01% 1679
2025
Q2
$70.6K Sell
225
-263
-54% -$79K ﹤0.01% 1662
2025
Q1
$149K Sell
488
-5
-1% -$1.68K ﹤0.01% 1239
2024
Q4
$164K Buy
+493
New +$167K ﹤0.01% 1214
2024
Q3
Sell
-515
Closed -$212K 1190
2024
Q2
$212K Buy
+515
New +$204K ﹤0.01% 1127

Other funds holding MEDP

MAI Capital Management's MEDP Position: Q2 2026 in Review

MAI Capital Management increased its Medpace (MEDP) stake by 71% in Q2 2026, buying an estimated $381K and bringing the position to 1,979 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #948.

MAI Capital Management first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • MAI Capital Management held 1,979 shares of Medpace worth $1.05M as of Q2 2026.
  • MAI Capital Management bought 825 Medpace shares in Q2 2026, an estimated $381K.
  • Medpace made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #948 holding.
  • MAI Capital Management first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.